Livemint

Centre caps trade margins on 137 cancer drugs, prices likely to fall by up to 70%

The NPPAs new rules target markups of up to 700% in some cases, covering widely used immunotherapies and targeted cancer treatments. Revised prices will be effective from 9 November.